Evaxion Biotech Boosts Share Capital With August 2026 ATM ADS OfferingTip Ranks·Sep 4 at 11:28 AMEVAX+0.97%
From Regional Bank Mergers to Psychedelic Meds: Inside the Market's Unclassified CornersGlobal Report·Sep 1 at 11:32 AMEVAX+0.97%BNC-3.81%
Beyond the Aggregators: Value Chains in the Physical and Regulated EconomyGlobal Report·Sep 1 at 09:18 AMUNP-0.48%CMI+1.22%
The Ultimate Leverage Game in AI Hardware: Moving Beyond NvidiaGlobal Report·Aug 30 at 11:34 AMSKHY+0.94%EVAX+0.97%
Biotech Bingo: Evaxion's AI Gamble and a Laser ETF Masquerading as PharmaGlobal Report·Aug 30 at 09:16 AMEVAX+0.97%
Evaxion releases transcript of Q2 2026 business update and financial results callPUBT·Aug 21 at 10:58 AMEVAX+0.97%
Evaxion Biotech: Strong R&D progress and financial discipline support a cash runway into H2 2027Quartr·Aug 20 at 11:48 PMEVAX+0.97%
Evaxion (EVAX) Q2 2026 Earnings Call: $14M Cash and EVX-01 UpdateTradingKey·Aug 20 at 08:02 PMEVAX+0.97%
Evaxion Biotech Q2 2026 Earnings Call: Complete Transcriptbenzinga_article·Aug 20 at 01:34 PMEVAX+0.97%
Evaxion Q2 FY26 net loss narrows to USD 3.7 million; revenue posts no revenuePUBT·Aug 20 at 11:30 AMEVAX+0.97%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Aug 19 at 09:05 PMEDSA-9.23%BIVI+1.05%
Evaxion adds EVX-05 off-the-shelf glioblastoma vaccine program to R&D pipelinePUBT·Aug 17 at 12:06 PMEVAX+0.97%
